ProfileGDS5678 / 1426784_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 77% 76% 77% 76% 76% 76% 77% 76% 75% 76% 76% 77% 76% 76% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 15.1894377
GSM967853U87-EV human glioblastoma xenograft - Control 25.1414776
GSM967854U87-EV human glioblastoma xenograft - Control 35.199177
GSM967855U87-EV human glioblastoma xenograft - Control 45.1830576
GSM967856U87-EV human glioblastoma xenograft - Control 55.1160276
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 15.0223176
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 25.1351877
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 35.1232676
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 45.0277275
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 15.1373276
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 25.1226276
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 35.3270277
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 45.138476
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 55.1291576